Skip to main content

Table 1 The demographic features of the study patients

From: Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease

 

MS (MVR) (n = 72)

MR (MVR) (n = 93)

AS (AVR) (n = 40)

AR (AVR) (n = 36)

P value

Age

52.23 ± 10.05

56.62 ± 12.07

63.52 ± 13.36

55.19 ± 14.21

0.000

HT (%)

5 (15.6)

15 (46.9)

7 (21.9)

5 (15.6)

0.008

DM (%)

20 (18.7)

47 (43.9)

22 (20.6)

18 (16.8)

0.284

History of Smoking (%)

22 (27.5)

28 (35)

15 (18.8)

15 (18.8)

0.547

TG (mg/dL)

116.18 ± 65.85

147.84 ± 95.40

143.32 ± 95.17

147.38 ± 75.42

0.087

LDL (mg/dL)

114.25 ± 32.06

112.37 ± 37.05

122.87 ± 39.35

114.88 ± 31.36

0.468

  1. HT, hypertension; DM, diabetes mellitus; TG, triglyceride; LDL, low-density lipoproteins; MS, mitral stenosis; MR, mitral regurgitation; MVR, mitral valve replacement; AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement.